-
Recent UK regulations restrict free refills of sugary drinks in hospitality venues and ban multi-buy deals on unhealthy foods to combat rising obesity. These measures, effective from October 2025, aim to promote healthier choices and reduce health risks like diabetes and heart disease, amid ongoing industry adjustments.
-
As of December 2025, the WHO has issued its first guidelines recommending long-term use of GLP-1 medications like Wegovy and Mounjaro for obesity treatment, recognizing obesity as a chronic disease. The US government has negotiated significant price cuts for these drugs, expanding Medicare and Medicaid coverage to more patients. However, concerns remain about drug accessibility, side effects, and weight regain after stopping treatment.
-
Local leaders in Charlotte and Chicago are preparing for potential federal immigration enforcement actions amid reports of planned operations. Community groups are training volunteers to protest and document actions, citing fears of invasion and racial profiling. No formal notifications have been received, but tensions are high as officials emphasize the city’s diverse immigrant populations.
-
Bank of England's Greene signals potential rate cuts if economic weakness persists, citing weak employment and consumption data. Markets expect a rate cut to 3.75% by end-2025 amid mixed economic signals, with inflation and wage growth key factors.
-
San Francisco has filed a lawsuit against 10 food and beverage companies, accusing them of marketing ultra-processed foods linked to health issues like obesity and diabetes. The city seeks penalties, consumer education, and restrictions on marketing, especially to children, citing scientific evidence of harm. The lawsuit marks a first for a U.S. municipality targeting such companies.